Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP62392.RA-iZutnpvq11dq9_C6AyzRqHmfJ6ZJxkivSPvIWdJHg4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP62392.RA-iZutnpvq11dq9_C6AyzRqHmfJ6ZJxkivSPvIWdJHg4130_assertion type Assertion NP62392.RA-iZutnpvq11dq9_C6AyzRqHmfJ6ZJxkivSPvIWdJHg4130_head.
- NP62392.RA-iZutnpvq11dq9_C6AyzRqHmfJ6ZJxkivSPvIWdJHg4130_assertion description "[In contrast, HLA-DRB1*1202 in the absence of HLA-B*1802 showed a significant association with resistance to recurrent PTB (p = 8.2 x 10(-4), odds ratio = 0.32, 95% confidence interval = 0.16-0.64), suggesting that stronger susceptibility effect of HLA-B*1802 masked the protective effect of HLA-DRB1*1202.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP62392.RA-iZutnpvq11dq9_C6AyzRqHmfJ6ZJxkivSPvIWdJHg4130_provenance.
- NP62392.RA-iZutnpvq11dq9_C6AyzRqHmfJ6ZJxkivSPvIWdJHg4130_assertion evidence source_evidence_literature NP62392.RA-iZutnpvq11dq9_C6AyzRqHmfJ6ZJxkivSPvIWdJHg4130_provenance.
- NP62392.RA-iZutnpvq11dq9_C6AyzRqHmfJ6ZJxkivSPvIWdJHg4130_assertion SIO_000772 20438789 NP62392.RA-iZutnpvq11dq9_C6AyzRqHmfJ6ZJxkivSPvIWdJHg4130_provenance.
- NP62392.RA-iZutnpvq11dq9_C6AyzRqHmfJ6ZJxkivSPvIWdJHg4130_assertion wasDerivedFrom gad-20130706 NP62392.RA-iZutnpvq11dq9_C6AyzRqHmfJ6ZJxkivSPvIWdJHg4130_provenance.
- NP62392.RA-iZutnpvq11dq9_C6AyzRqHmfJ6ZJxkivSPvIWdJHg4130_assertion wasGeneratedBy ECO_0000203 NP62392.RA-iZutnpvq11dq9_C6AyzRqHmfJ6ZJxkivSPvIWdJHg4130_provenance.